This suggests that malnutrition irrespective of CF is associated with higher ADP levels and with increasing body weight after the new highly effective modulator therapy, factors such as fat mass, ADP levels and hepatic insulin sensitivity may become more important in the development of glucose intolerance in CF. This evidence concerns the gene INS and Glucose intolerance.